FDA Determines Regulatory Review Period for MITRACLIP CDS Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for MITRACLIP CDS, a medical device patent extension, as required by law after receiving patent extension applications from the US Patent and Trademark Office (USPTO).